A drug safety watchdog has renewed its criticism of the government's approval of a Parkinson's psychosis medication and is calling for stronger warnings on its label for patients and their families.
The US Department of Justice has launched an investigation into the sales and marketing of a drug approved three years ago to help treat Parkinson's patients suffering from debilitating psychosis.
The Food and Drug Administration announced Thursday it had not identified any "new or unexpected safety findings" related to a drug used to treat psychosis in Parkinson's patients, though it did find potentially troubling prescribing practices.
The Food and Drug Administration says it is re-examining the safety of a medication that was approved despite concerns that not enough was known about the drug's risks.
Two years ago, Brendan Tyne pleaded with the Food and Drug Administration to approve a drug that he was hopeful could finally bring his mother some peace.
